Abstract:
Systems, methods, and techniques of rewarding spending and loyalty that includes obtaining from a participant a commitment to purchase goods and services from vendors and rewarding participants based on participant purchases are provided. Rewards include a distribution from a rewards fund established, for example, from commissions paid by vendors to the program administrator based in part upon purchases from the vendors by program participants. Rewards are distributed to participants preferably at defined periods or stages, such as a defined period of time of staying married, an age, or a level of purchasing from program vendors. This abstract is provided to comply with rules requiring an abstract, and it is submitted with the intention that it will not be used to interpret or limit the scope or meaning of the claims.
Abstract:
Systems, methods, and techniques of rewarding spending and loyalty that includes obtaining from a participant a commitment to purchase goods and services from vendors and rewarding participants based on participant purchases are provided. Rewards include a distribution from a rewards fund established, for example, from commissions paid by vendors to the program administrator based in part upon purchases from the vendors by program participants. Rewards are distributed to participants preferably at defined periods or stages, such as a defined period of time of staying married, an age, or a level of purchasing from program vendors. This abstract is provided to comply with rules requiring an abstract, and it is submitted with the intention that it will not be used to interpret or limit the scope or meaning of the claims.
Abstract:
The present invention relates to dendrimer compositions configured for treating inflammatory disorders and autoimmune disorders, and related methods of synthesis. Specifically, the present invention relates to methods for treating rheumatoid arthritis with PAMAM dendrimers having functional ligands configured for treating rheumatoid arthritis (e.g., therapeutic agents, pro-drugs, targeting agents, trigger agents, imaging agents) (e.g., methotrexate).
Abstract:
The present invention relates to dendrimer compositions configured for treating inflammatory disorders and autoimmune disorders, and related methods of synthesis. Specifically, the present invention relates to methods for treating rheumatoid arthritis with PAMAM dendrimers having functional ligands configured for treating rheumatoid arthritis (e.g., therapeutic agents, pro-drugs, targeting agents, trigger agents, imaging agents) (e.g., methotrexate).